Does Rallies track congressional trades in BDX?

Yes. Rallies tracks politician and congressional stock disclosures for BDX, including reported purchases, sales, dates, owners, and trade amounts when available.

Is BDX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BDX. It does not provide personalized investment advice.

BDX (Becton, Dickinson and Co.) Stock Analysis - Politician Trades

Becton, Dickinson and Co. (BDX) is a publicly traded Healthcare sector company. As of May 20, 2026, BDX trades at $147.16 with a market cap of $39.22B and a P/E ratio of 37.18. BDX moved +0.07% today. Year to date, BDX is -24.62%; over the trailing twelve months it is -17.00%. Its 52-week range spans $141.82 to $251.99. Analyst consensus is buy with an average price target of $182.20. Rallies surfaces BDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded BDX stock?

Recent politician trading activity in BDX includes disclosures from Rob Bresnahan, Thomas H. Kean, Jefferson Shreve, William R. Keating, and Ro Khanna. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

BDX Key Metrics

Key financial metrics for BDX
Metric	Value
Price	$147.16
Market Cap	$39.22B
P/E Ratio	37.18
EPS	$3.95
Dividend Yield	1.05%
52-Week High	$251.99
52-Week Low	$141.82
Volume	2.06M
Avg Volume	0
Revenue (TTM)	$21.37B
Net Income	$1.14B
Gross Margin	46.79%

Congressional Trades in BDX

Rob Bresnahan purchase BDX on May 15, 2025 (amount: $15.00K).
Thomas H. Kean purchase BDX on May 13, 2025 (amount: $15.00K).
Jefferson Shreve sale BDX on Mar 5, 2025 (amount: $50.00K).
William R. Keating sale BDX on Sep 11, 2024 (amount: $15.00K).
Ro Khanna sale BDX on Sep 9, 2024 (amount: $15.00K) for Spouse.

Latest BDX News

BDX jumps after Q2 results, raised FY26 adjusted EPS guidance, new CFO named — May 7, 2026
Becton Dickinson to Deploy AI-Powered Pyxis Pro and Alaris Systems at Wellstar — May 5, 2026
Becton Dickinson Earns 2026 Best Employers Health Award, Cigna Gold Workforce Designation — Apr 30, 2026
BDX slides 3% ahead of April 30 earnings as Alaris overhang returns — Apr 29, 2026
Becton Dickinson Launches CentroVena One™ System Cutting Steps by 30% — Apr 29, 2026

Recent BDX Insider Trades

Feld Michael sold 74 (~$11.24K) on Apr 27, 2026.
Feld Michael sold 75 (~$11.76K) on Mar 26, 2026.
Feld Michael sold 75 (~$13.64K) on Feb 26, 2026.

BDX Analyst Consensus

10 analysts cover BDX: 0 strong buy, 5 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $182.20.

Common questions about BDX

Which politicians traded BDX stock?: Recent politician trading activity in BDX includes disclosures from Rob Bresnahan, Thomas H. Kean, Jefferson Shreve, William R. Keating, and Ro Khanna. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in BDX?: Yes. Rallies tracks politician and congressional stock disclosures for BDX, including reported purchases, sales, dates, owners, and trade amounts when available.
Is BDX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BDX. It does not provide personalized investment advice.